Katherine Stueland - Sep 16, 2024 Form 4 Insider Report for GeneDx Holdings Corp. (WGS)

Role: Chief Executive Officer, Director
Signature: /s/ Bridget Brown, Attorney-in-Fact
Stock symbol: WGS
Transactions as of: Sep 16, 2024
Transactions value $: -$394,733
Form type: 4
Date filed: 9/18/2024, 04:28 PM
Previous filing: Sep 11, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	WGS	Class A Common Stock	Options Exercise	$0	+18.8K	+19.64%	$0.00	114K	Sep 16, 2024	Direct	F1
transaction	WGS	Class A Common Stock	Sale	-$395K	-10.5K	-9.19%	$37.59	104K	Sep 16, 2024	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	WGS	Restricted Stock Unit	Options Exercise	$0	-18.8K	-9.09%	$0.00	188K	Sep 16, 2024	Class A Common Stock	18.8K		Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.
F2	The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sales were to satisfy tax withholding obligations to be funded by a "sell to cover" transaction.
F3	6.25% vest in quarterly installments over the 4-year period commencing on March 16, 2023 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.